Press Releases Items Per Page 102550 Year None2023202220212020201920182017201620152014201320122011201020092008 June 30, 2020 Revance Announces Positive Results in Two Phase 2a Studies of DaxibotulinumtoxinA For Injection for the Treatment of Forehead Lines and Crow’s Feet, Respectively June 4, 2020 Revance to Participate in the 40th Annual William Blair Growth Stock Conference June 2, 2020 Revance to Present at the Goldman Sachs 41st Annual Global Healthcare Conference Webcast June 1, 2020 Revance and Mylan to Advance Development Program for Biosimilar to BOTOX® May 19, 2020 Revance Announces Agreement to Acquire HintMD and its Proprietary Fintech Platform for Aesthetic Practices May 7, 2020 Revance Reports First Quarter 2020 Financial Results, Provides Corporate Update May 1, 2020 Revance and Mylan Biosimilar to BOTOX® Program Decision to Extend Beyond April 30, 2020 April 30, 2020 Revance to Release First Quarter 2020 Financial Results on Thursday, May 7, 2020 April 7, 2020 Revance to Participate in the 19th Annual Needham Virtual Healthcare Conference March 26, 2020 Revance Provides Corporate Update in Light of COVID-19 Pagination First page « first Previous page ‹ previous … Page 6 Page 7 Page 8 Page 9 Current page 10 Page 11 Page 12 Page 13 Page 14 … Next page next › Last page last » Displaying 91 - 100 of 298